01.03.2017
- In the course of only a week, the US Food and Drug Administration FDA) has accepted the second Biologics License Application (BLA) for priority review. In the latest case, the...
25.10.2016
- Major drugmakers Merck KGaA of Germany and Pfizer of the US are collaborating with Debiopharm International, a drug developer based in Lausanne, Switzerland to study the potential...
07.01.2016
- Germany’s Merck KGaA and Pfizer of the US are collaborating with US biopharmaceutical company Syndax to evaluate a combination of avelumab and entinostat to treat advanced ovarian...
19.11.2015
- A further regulatory milestone has been achieved by Merck KGaA and Pfizer after the US Food and Drug Administration (FDA) designated their potential skin cancer treatment avelumab...
